Rapid-acting antidepressants, including ketamine, scopolamine and psilocybin, have been found to have immediate and lasting positive effects on mood in patients with major depressive disorder but how these effects arise is unknown. New research has explored their neuropsychological effects and found that all three of these drugs can modulate affective biases associated with learning and memory.
